|
gptkbp:instanceOf
|
gptkb:chemical_compound
|
|
gptkbp:actsOn
|
gptkb:REV-ERBα
gptkb:REV-ERBβ
|
|
gptkbp:alsoKnownAs
|
gptkb:Stenabolic
|
|
gptkbp:canBe
|
research chemical
exercise endurance research
metabolic disorders research
study of circadian rhythm
|
|
gptkbp:CASNumber
|
1379686-30-2
|
|
gptkbp:category
|
investigational drug
performance-enhancing substance (unapproved)
|
|
gptkbp:developedBy
|
gptkb:The_Scripps_Research_Institute
|
|
gptkbp:discoveredIn
|
2012
|
|
gptkbp:function
|
REV-ERB agonist
|
|
gptkbp:hasMolecularFormula
|
C20H24ClN3O4S
|
|
gptkbp:hasSMILES
|
CC1=CC=C(C=C1)S(=O)(=O)C=CC(=O)NC2=CC=C(C=C2)Cl
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
SR 90005
|
|
gptkbp:IUPACName
|
gptkb:(E)-N-(4-chlorophenyl)-3-((2,5-dimethylphenyl)sulfonyl)acrylamide
|
|
gptkbp:legalStatus
|
not approved for human use
|
|
gptkbp:molecularWeight
|
437.94 g/mol
|
|
gptkbp:PubChem_CID
|
gptkb:CHEMBL2326985
49853714
|
|
gptkbp:routeOfAdministration
|
oral
|
|
gptkbp:synonym
|
gptkb:Stenabolic
|
|
gptkbp:UNII
|
6Z5B6HVF6O
|
|
gptkbp:bfsParent
|
gptkb:SR_90005_(Virginia)
|
|
gptkbp:bfsLayer
|
7
|